naltrexone
Studies associated with:
| Division | Study Number | Title | Investigator(s) | Release Date |
|---|---|---|---|---|
| CTN | NIDA-CTN-0069 | Opioid Use Disorder in the Emergency Department (ED-HEALTH) | David A. Fiellin, M.D., Gail D'Onofrio, M.D., M.S. | |
| CTN | NIDA-CTN-0097 | Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone (SWIFT) | Adam Bisaga, M.D., Edward V. Nunes, M.D. | |
| CTN | NIDA-CTN-0079 | Emergency Department Connection to Care with Buprenorphine for Opioid Use Disorder (ED-CONNECT) | John Rotrosen, M.D., Kathryn Hawk, M.D., M.H.S., Ryan McCormack, M.D. | |
| CTN | NIDA-CTN-0095A2 | Reducing Stigma toward People with Opioid Use Disorder among Primary Care Clinicians | Stephanie Hooker, Ph.D., M.P.H., Rebecca Rossom, M.D., M.S., A. Lauren Crain, Ph.D., Gavin Bart, Ph.D., M.D. | |
| CTN | NIDA-CTN-0055 | Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study (CHOICES) | P. Todd Korthuis, MD | |
| CTN | NIDA-CTN-0067 | Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up | P. Todd Korthuis, MD | |
| CTN | NIDA-CTN-0068 | Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT-2) | Madhukar H. Trivedi, M.D. | |
| CTN | NIDA-CTN-0054 | Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT) | Walter Ling, M.D. | |
| CTN | NIDA-CTN-0051 | Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment | John Rotrosen, M.D. | |
| CTN | NIDA-CTN-0048 | Cocaine Use Reduction with Buprenorphine (CURB) | Walter Ling, M.D. |